Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
47 Мб
Скачать
41 Pelvic Reconstruc tive Procedures
465
plan. Finally, one must review all previous opera­tive procedures and available imaging to prevent errors from poor ap selection.

Intraoperative

Wide surgical preparation and draping of the pel­vis and donor sites is essential for exposure. A position change may be required to appropriately access and mobilize donor tissue, such as switch­ing to prone positioning to elevate gluteal aps for posterior perineal defects.
In addition to antiseptic skin preparation, pro­phylactic intravenous antibiotics should be administered within 60 minutes of the start of surgery and re-dosed as indicated to prevent infection. Every effort should be made to opti­mize surgical efciency to decrease operative time as lengthy surgeries have increased risks of complications [5].
The reconstructive surgeon must rst criti­cally evaluate the extent of the anatomic defect including deep space and skin involvement (Fig.41.1). Any heavily radiated, devitalized, or traumatized tissue that remains should be debrided back to healthy, vascularized tissue to
facilitate healing. It is important to wait until the nal debridement before nalizing your ap design.
Thoughtful and meticulous ap design, dis­section, and inset are imperative in achieving a successful reconstruction.
In cases of a large pelvic defect with a deep space component, the surgical plan should include obliteration of the dead space with bulky muscle, omental or de-epithelized aps. The extra tissue helps cover exposed pelvic structures and mechanically supports the internal organs. This can effectively prevent internal herniation, prolapse and uid collection which all predispose the patient to infection, incisional dehiscence, and stulae [3, 4, 8, 15].
In cases of a large skin defect, the ap should incorporate a skin paddle to replace the resected perineal skin. Otherwise, there would be undue tension on primary skin closure and an increased risk of incisional dehiscence [3]. A skin paddle can also be utilized to resurface vaginal defects. Intraoperative templates are useful in designing the ap dimensions. However, the skin paddle should be slightly oversized to account for tissue thickness, edema, and rotation, and to avoid a tight closure which could compress the vascular pedicle [16] (Fig.41.2).
When designing and elevating aps, the reconstructive surgeon must have a thorough understanding of the vascularity of the various aps including pedicle location, arc of rotation,
Fig. 41.1 Large pelvic defect with internal dead space and external skin defect
Fig. 41.2 Flap design based on an intraoperative tem­plate of a perineal defect made with hydrocolloid dressing
466
J. Pribaz and K. Whalen
and location and reliability of cutaneous perfora­tors. With this knowledge, surgeons can make modications to ap design to meet the unique requirements of the defect [17]. Dominant perfo­rators should be incorporated into the ap design when feasible to improve vascularity. A handheld doppler is helpful in identifying perforators for this purpose.
In the case of rectus abdominis aps, design­ing the skin paddle over the robust periumbilical perforators improves perfusion. The skin paddle can also be oriented obliquely and extend beyond the costal margin to increase the length of the ap for use in large or posteriorly oriented defects [18, 19]. Any part of the ap that cannot reach the perineum should be de-epithelialized rather than de-skinned because maintenance of the dermal plexus improves vascularity to the distally ori­ented skin paddle. Leaving the inferior attach­ment of the rectus muscle is advised to prevent stretching, twisting, kinking, or avulsion of the vascular pedicle once it is transposed into the pel­vis (Fig.41.3).
For advancement aps from the thigh or but­tocks, the ap should be designed large enough to include reliable perforators, provide sufcient skin coverage, and allow for ap re-advancement if needed [19]. The leading edges can also be de­epithelialized to ll internal dead space (Fig.41.4).
It is important to discuss preserving the omen­tum with the extirpative surgeons if you are plan­ning to incorporate it into the reconstruction. The omentum should be adequately dissected based on the right or left gastroepiploic pedicle to avoid tension on the blood supply and prevent a tight intrabdominal band that may lead to internal her­nia [7].
Once the ap has been elevated, it can be transferred to the recipient site. One must release all scar contractures and radiated tissue to avoid constriction and pressure on the ap, which can develop once postoperative edema has set in. If there is any concern about the vascularity of the ap, the subcutaneous tunnel should be released to accommodate the transferred tissue. The skin paddle can be extended to include a wide skin bridge to cover the tracks of the pedicled ap and eliminate the need for a tunnel (Fig.41.5).
When performing free tissue transfer (which is uncommon, due to the large number of regional ap options), recipient vessels must be inspected
Fig. 41.3 Design of an extended oblique vertical rectus abdominus myocutaneous (VRAM) ap. Note the intra­pelvic portion is de-epithelialized to preserve the subder­mal plexus and the inferior muscular attachment to the pubis is maintained to prevent pedicle kinking, twisting, and avulsion when transferring the ap into the pelvis
Fig. 41.4 Design of bilateral V-Y gluteal fasciocutane­ous aps for secondary reconstruction after dehiscence and distal ap necrosis of a VRAM ap. Note the leading edges are marked for de-epithelialization to ll internal dead space
41 Pelvic Reconstruc tive Procedures
Fig. 41.5 Right pedicled anterolateral thigh with an extended skin paddle to cover the pedicle’s course and prevent the need for a constrictive subcutaneous tunnel
intraoperatively to ensure they are intact and out­side of the zone of radiation. If local vessels are unavailable, an arteriovenous vascular loop from regional vessels can be created with a vein graft [20].
Intraoperative ap perfusion can be assessed by observing clinical bleeding patterns or by the use of SPY angiography technology. Tissue with evidence of poor blood ow should be excised prior to ap inset.
In addition to the recipient site, one must also consider the donor site’s morbidity. To reduce the risk of bulge or herniation formation after trans­fer of rectus abdominis muscles, it is critical to restore the abdominal wall. The fascia can be closed primarily when harvesting a muscle-only rectus abdominis ap. In cases that require a myocutaneous ap, the anterior rectus sheath and overlying soft tissue are harvested with the mus­cle resulting in a fascial defect. Adjunctive tech­niques to reduce abdominal wall morbidity in this setting include fascia-sparing rectus muscle har­vest with primary fascial closure, component separation with primary fascial closure, or place­ment of an inlay mesh that is inset on proper ana­tomic tension [15, 18]. Biologic mesh should be considered in contaminated or infected wound beds.
In patients where the abdominal donor site is not available due to previous surgeries or multi­ple ostomies, the thigh or gluteal tissue can be used. These aps are ideally harvested as fascio-
467
cutaneous aps in ambulatory patients to pre­serve mobility [8, 14]. A pinch test veries that the donor site can be closed primarily without excessive tension. Incisions should be oriented along resting skin tension lines to allow for larger ap harvest and inconspicuous donor site clo­sure. Skin grafting of the donor site may be required if it cannot be closed primarily.
Measures should be taken to prevent uid col­lection which can later become a source of infec­tion. Careful hemostasis is essential during all stages of the operation. Multiple drains should be placed including at least one large caliber drain in the pelvis and a drain beneath the ap. Progressive tension sutures can also be considered to mini­mize dead space at the donor site.
The ap should be inset loosely to prevent kinking of the pedicle or perforators [7]. A metic­ulous multilayer, water-tight cutaneous closure should be performed while avoiding overly tight­ened sutures that can result in tissue necrosis.
There are several options for dressings and the choice is often surgeon dependent. The ideal dressing absorbs drainage, protects the incision from shear forces, minimizes trauma to surround­ing skin, and allows regular monitoring of the incision and aps by the surgical team. Absorbent abdominal gauze pads and mesh panties are sim­ple, cheap and achieve the above goals. Dressings should be changed at least daily and as needed for saturation or contamination.

Postoperative

Protocols vary based on surgeon and institutional preference, but postoperative activity modica­tion and positioning is critical in preventing pres­sure induced necrosis and dehiscence in the early postoperative period. Optimal positioning depends on the exact location of the ap but ranges from prone to supine and lateral decubi­tus. Air-uidized mattresses are a useful adjunct for pressure ofoading. Some surgeons opt for bed rest for the rst 1–3 days, while others encourage early ambulation to prevent venous thromboembolism. Sitting or waist exion greater than 30 degrees is generally prohibited
468
J. Pribaz and K. Whalen
for 3–6weeks to avoid direct pressure on the ap and tension on the skin closure. Once patients start ambulating, they should be instructed to log­roll to stand with the guidance of a physical ther­apist [2, 4, 9].
Due to the dependent nature of these surgical sites, the incisions are prone to uid egression and maceration. It is important to keep the inci­sions dry with frequent dry dressing changes. Closed suction drains should be maintained for several weeks until output is less than approxi­mately 30cc per day to prevent uid collections in gravity-dependent zones [2, 4]. It is also advis­able to leave perineal drains in place until the intrabdominal drains have been removed by the extirpative surgeons. Sutures are removed once incisions are fully healed.
Postoperative antibiotics, especially in patients with foreign materials such as mesh, should be considered to prevent infection. Patients are closely monitored for derangements such as anemia, hyperglycemia, hypothermia, hypovolemia, and malnutrition and optimized accordingly.

Recognition

Fluid Collection

Supercial uid collections can be palpated on exam and may be associated with incisional drainage. Clear drainage is most consistent with a seroma but can also indicate a urine leak. Sanguineous drainage suggests a hematoma and purulence is concerning for an abscess. Laboratory studies are useful to evaluate for associated anemia or leukocytosis. Fluid analysis including culture, cytology, and creatinine can also help determine the etiology of the collection and guide treatment.

Infection

Supercial infection can be diagnosed on exam with ndings of warmth, erythema, edema, and tenderness. Deeper organ space infections are best identied with imaging such as ultrasound or computed tomography. Signicant pain, necrotic tissue with malodorous drainage, and rapidly progressive sepsis are signs of a serious necrotizing soft tissue infection. This clinical diagnosis requires a high index of suspicion and warrants prompt surgical exploration.
Early identication of complications is best achieved with close postoperative monitoring. Patients are typically hospitalized for 7 to 14days and seen in the clinic weekly or biweekly until drains are removed and complete healing is observed.
Wound Dehiscence andDelayed Wound Healing
Delayed wound healing is the most common complication after female pelvic reconstructive surgery and requires timely diagnosis and treat­ment. Wound dehiscence or delayed healing is recognized on exam as lack of completely opposed skin edges greater than two weeks after surgery.

Partial or Total Flap Loss

Pedicled and free aps are susceptible to vascular compromise by pedicle compression, clotting, or kinking which necessitate timely intervention in the operating room to prevent ap loss [2]. These patients should be closely monitored postopera­tively by experienced clinicians with serial ap checks which include ap color, turgor, capillary rell, temperature, and doppler when applicable. Flaps that are pale, cool and have weak or absent arterial doppler signals and slow capillary rell likely have arterial insufciency. Flaps with dark, purplish discoloration, edema, and brisk capillary rell are suffering from venous insufciency. Early recognition of a perfusion problem is essential in salvaging aps.
41 Pelvic Reconstruc tive Procedures
469

Fistula

Fistulae can be identied on exam by abnormal connections between anatomic structures such as the skin, bladder, vagina, and rectum. Patients may note abnormal drainage as well. Static and dynamic imaging can be helpful in further char­acterization of the stula.

Donor Site Complications

Donor site hernia can be diagnosed as a palpable bulge on physical exam or with computed tomo­graphic scans. As with ap recipient sites, donor sites are also subject to wound dehiscence, uid collections, and infection and are recognized as above. In the case of abdominal incisional dehis­cence, the wound should be gently probed or imaged to assess for fascial integrity.

Management

Wound Dehiscence andDelayed Wound Healing
Small wounds that are supercial and involve less than one-third of the incision can be man­aged conservatively with local wound care such as saline moist-to-dry gauze packing. These wounds typically completely heal by secondary intention. Larger wounds can be treated with negative- pressure wound therapy or operative debridement and secondary closure to accelerate healing. Expedited healing is especially impor­tant when the patient requires adjuvant therapy [2, 11].

Fluid Collection

Fluid collections including hematoma, seroma, and abscesses should be treated with percutane­ous or open drainage. A simple seroma can be treated with serial aspiration or drain placement. A larger, persistent collection or abscess may necessitate extensive incision and drainage. In
the case of an abscess, patients should be placed on culture-directed antibiotic therapy. A patient with a suspected urine leak should be evaluated and treated by the appropriate surgical team.

Infection

Cellulitis and local wound infection dened as localized erythema without uid collection or dehiscence can be treated with antibiotic therapy.
Open, infected wounds are best treated with frequent dressing changes that promote mechani­cal debridement and drainage of purulent and necrotic tissue. Loosely packed moist-to-dry dressings with saline or Dakin’s solution can be utilized for this purpose.
Deep organ space infections are diagnosed on imaging or re-exploration and are often dealt with by the ablative surgeon with serial debride­ment, removal of infected prosthetics, drain placement, and infectious disease consultation for antibiotic management.

Partial or Total Flap Loss

If a ap shows acute signs of arterial or venous insufciency, it should be explored in the operat­ing room emergently. One must investigate the pedicle for compression or kinking. In the case of a free ap, the arterial or venous anastomosis needs to be revised if there is a clot present.
Flaps that have early signs of venous conges­tion can be treated conservatively with leech therapy to improve ap circulation [21]. Progressive venous insufciency warrants opera­tive exploration as above.
Partial ap loss, dened as necrosis involving less than one-third of the ap volume, should be treated with bedside or formal operative debride­ment once the necrotic tissue has fully demar­cated. This can be followed by local wound care, negative-pressure wound therapy, delayed pri­mary closure, or ap re-advancement.
When larger or total ap loss occurs, the non­viable ap should be excised in the operating
470
J. Pribaz and K. Whalen
ab
Fig. 41.6 (a) Right pedicled gracilis muscle ap isolated on its vascular pedicle. (b) Gracilis muscle ap inset for repair of rectovaginal stula
room. The resulting defect can be temporized with negative-pressure wound therapy until
Donor site dehiscence, uid collections, and infection are treated as above.
denitive reconstruction with a lifeboat ap is performed. One should already have a secondary and tertiary reconstructive option in mind in the

Conclusion

event of ap loss (Fig.41.5a–b).
Reconstruction plays an important role in facili­tating extensive pelvic resections in the setting

Fistula

of malignancy. Complications are unfortunately a reality of reconstructive surgery and com-
Extensive stulae can be addressed with a muscle or musculocutaneous ap to obliterate dead space and separate the involved anatomic organs. The gracilis ap is an ideal choice as it is located out­side of the eld of radiation and is typically spared in abdominal-based extirpative surgeries (Fig.41.6a–b) [22, 23].

Donor Site Complications

monly occur in the pelvis due to its poor wound­healing environment. It is imperative to minimize risks at every stage of patient care, carefully analyze complications when they do occur, be prepared with a lifeboat for salvage reconstruction, and learn from mistakes to pre­vent them in the future.

References

A clinically signicant donor site hernia or bulge can be addressed with exploration and repair with inlay or only mesh for abdominal wall support.
1. Witte DYS, van Ramshorst GH, Lapid O, Bouman M-B, Tuynman JB. Flap reconstruction of peri­neal defects after pelvic exenteration: a systematic description of four choices of surgical reconstruction
41 Pelvic Reconstruc tive Procedures
471
methods. Plast Reconstr Surg. 2021;147(6):1420–35.
https://doi.org/10.1097/prs.0000000000007976.
2. Hollenbeck ST, Toranto JD, Taylor BJ, etal. Perineal and lower extremity reconstruction. Plast Reconstr Surg. 2011;128(5):551e–63e. https://doi.org/10.1097/
PRS.0b013e31822b6b87.
3. Devulapalli C, Jia Wei AT, DiBiagio JR, etal. Primary versus ap closure of perineal defects following oncologic resection: a systematic review and meta­analysis. Plast Reconstr Surg. 2016;137(5):1602–13.
https://doi.org/10.1097/prs.0000000000002107.
4. Wang ED, Conkling N, Xu X, et al. Perineal ap reconstruction following oncologic anorectal extirpa­tion: an outcomes assessment. Plast Reconstr Surg. 2015;135(1):176e–84e. https://doi.org/10.1097/
prs.0000000000000837.
5. Jones HW, Rock JA.Te Linde’s operative gynecology. In: Jones HW, Rock JA, editors. Books@Ovid. 11th ed. Wolters Kluwer; 2015.
6. Weichman KE, Matros E, Disa JJ. Reconstruction of peripelvic oncologic defects. Plast Reconstr Surg. 2017;140(4):601e–12e. https://doi.org/10.1097/
prs.0000000000003703.
7. Westbom C, Talbot S. An Algorithmic Approach to Perineal Reconstruction. Plast Reconstr Surg Glob Open. 2019;7(12):e2572. https://doi.org/10.1097/
GOX.0000000000002572.
8. Bialowas C, Nguyen B, Patel A. Best solutions for perineal and pressure sore reconstruction. Plast Reconstr Surg. 2021;148(6):1026e–39e. https://doi.
org/10.1097/prs.0000000000008509.
9. Mericli AF, Martin JP, Campbell CA.An algorithmic anatomical subunit approach to pelvic wound recon­struction. Plast Reconstr Surg. 2016;137(3):1004–17.
https://doi.org/10.1097/01.prs.0000479973.45051.b6.
10. Larson EL, McGinley KJ, Foglia AR, Talbot GH, Leyden JJ. Composition and antimicrobic resis­tance of skin ora in hospitalized and healthy adults. J Clin Microbiol. 1986;23(3):604–8. https://doi.
org/10.1128/jcm.23.3.604- 608.1986.
11. Nelson RA, Butler CE.Surgical outcomes of VRAM versus thigh aps for immediate reconstruction of pelvic and perineal cancer resection defects. Plast Reconstr Surg. 2009;123(1):175–83. https://doi.
org/10.1097/PRS.0b013e3181904df7.
12. Kim JT, Yew Ming Ho S, Hwang JH, Lee JH.Perineal perforator-based island aps: the next frontier in perineal reconstruction. Plast Reconstr Surg. 2014;133(5):683e–7e. https://doi.org/10.1097/
prs.0000000000000146.
13. Zeiderman MR, Nuño M, Sahar DE, Farkas LM.Trends in ap reconstruction of pelvic oncologic defects: analysis of the national inpatient sample. J
Plast Reconstr Aesthet Surg. 2021;74(9):2085–94.
https://doi.org/10.1016/j.bjps.2020.12.067.
14. Althumairi AA, Canner JK, Gearhart SL, Safar B, Sacks J, Efron JE. Predictors of perineal wound complications and prolonged time to perineal wound healing after abdominoperineal resection. World J Surg. 2016;40(7):1755–62. https://doi.org/10.1007/
s00268- 016- 3450- 0.
15. Campbell CA, Butler CE. Use of adjuvant tech­niques improves surgical outcomes of complex vertical rectus abdominis myocutaneous ap recon­structions of pelvic cancer defects. Plast Reconstr Surg. 2011;128(2):447–58. https://doi.org/10.1097/
PRS.0b013e31821e6fd2.
16. Driessen C, van Hout N, van Kuppenveld P, et al. Usefulness of a template-based anterolateral thigh ap for reconstruction of head and neck defects. Microsurgery. 2020;40(7):776–82. https://doi.
org/10.1002/micr.30637.
17. Weinstein B, King KS, Triggs W, Harrington MA, Pribaz J.Bilobed gracilis ap: a novel alternative for pelvic and perineal reconstruction. Plast Reconstr Surg. 2020;145(1):231.
18. Baumann DP, Butler CE. Component separation improves outcomes in VRAM ap donor sites with excessive fascial tension. Plast Reconstr Surg. 2010;126(5):1573–80. https://doi.org/10.1097/
PRS.0b013e3181ef8d00.
19. Mougalian SS, Soulos PR, Killelea BK, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. 2015;121(15):2544–52. https://doi.org/10.1002/
cncr.29348.
20. Wong S, Garvey P, Skibber J, Yu P.Reconstruction of pelvic exenteration defects with anterolateral thigh–vastus lateralis muscle aps. Plast Reconstr Surg. 2009;124(4):1177–85. https://doi.org/10.1097/
PRS.0b013e3181b5a40f.
21. Hackenberger PN, Janis JE. A comprehen­sive review of medicinal leeches in plastic and reconstructive surgery. Plast Reconstr Surg Glob Open. 2019;7(12):e2555. https://doi.org/10.1097/
gox.0000000000002555.
22. Hotouras A, Ribas Y, Zakeri S, Murphy J, Bhan C, Chan CL.Gracilis muscle interposition for rectovagi­nal and anovaginal stula repair: a systematic litera­ture review. Color Dis. 2015;17(2):104–10. https://
doi.org/10.1111/codi.12791.
23. Zhang C, Yang X, Bi H. Application of depithe­lized gracilis adipofascial ap for pelvic oor reconstruction after pelvic exenteration. BMC Surg. 2022;22(1):304. https://doi.org/10.1186/
s12893- 022- 01755- 0.

Index

A
Abdominal perineal resection (APR), 389 Abdominal wall problems, 435 Abdominal wound infection, 432 Ablative procedures, 338 Abnormal placentation, 51, 52, 312 Activated partial thromboplastin time (aPTT), 7 Active voiding trial, 369 Acute coagulopathy, 313 Acute enteritis, 396, 397 Adhesiolysis, 441 Adjunctive techniques, 467 Aging-related impairments, 24, 26, 27 Alvimopan, 15, 16 Anal cancer, 394 Anal sphincteroplasty, 342 Anal squamous cell carcinoma, 388, 395 Anastomotic bleeding, 408 Anastomotic leak, 161 Anastomotic strictures, 406, 408 Angular pregnancies, 306 Anorectal and urinary problems, 435 Anorectal stula, 215, 216 Anorectal manometry, 223 Antegrade colonic irrigation, 344 Anticoagulation, 7 Anus, anal margin, and vulvar, 421 Apical tenderness, 373 APR/ELAPE for rectal cancer, 391 Arterial embolization, 360 Asherman’s syndrome, 47
B
Bilateral uterine artery ligation, 294 Bilateral V-Y gluteal fasciocutaneous aps, 466 Bipolar thermal energy, 283 Bladder cancer (BCa), 117 Bladder defects, 328 Bladder dysfunction, 368, 369 Bladder injury, 297, 298, 327, 366, 367
during pelvic dissection, 281 management, 65, 66, 281, 282 prevention, 64 recognition, 64, 65
risk factors, 64 Bladder toxicity, 419 Body image/psychological issues, 434 Bowel injury, 67, 68, 247, 248, 298
and complications, 441, 442
genital tract prolapse, 76 Bowel obstruction, 433 Brachytherapy, 417, 418
C
Carbohydrate loading, 14 Carbon dioxide embolism, 247 CAUTI, 371 Cellulitis and local wound infection, 469 Cervical and cesarean scar ectopic pregnancy, 306, 307 Cervical injury, 313, 314 Cesarean birth, 291 Cesarean delivery, 294 Cesarean hysterectomy, 293
incidence, 319
PAS, 321, 322, 324, 325 Charles procedure, 338 Charlson comorbidity index, 429 Chemoprophylaxis, 4–6 Chemoradiotherapy (CRT), 387 Chylous ascites, 361 Clinical coagulopathy, 327 Clitoral-sparing surgery, 345 Colonic reservoir, 148, 149 Colo-rectal anastomosis, 432 Colorectal anastomotic leak (AL), 401–403 Colorectal dysfunction, 369, 370 Colorectal malignancies, 439 Colorectal surgery, 441 Complex advanced stula therapy, 216, 217 Complex pelvic sidewall anatomy, 440
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2025 M. Hoffman et al. (eds.), Major Complications of Female Pelvic Surgery,
https://doi.org/10.1007/978-3-031-66772-5
473
474
Index
Composite pelvic resection, ovarian cancer
anastomotic bleeding, 384 anastomotic leak, 381–383 anastomotic stricture, 384, 385 bowel injury, 383, 384 post-operative hemorrhage, 378, 379 ureteral injury, 379, 380 vascular injury, 377, 378
Computed tomography pulmonary angiography
(CT-PE), 7 Conduit necrosis, 161 Contemporary cesarean delivery of a term infant, 294 Continent cutaneous urinary diversion (CCUD)
afferent segment, 152 colonic reservoir, 148, 149 efferent segment, 150, 152 ileal reservoir, 149 ileocaecal reservoir, 146–148 incidence, 145
outcome, complications, and gender, 149, 150 Continuous bladder irrigation (CBI), 119 Cornuostomy, 306 Crohn’s disease, 215, 216 Cryptoglandular abscess, 207–209 Cystitis, 120
D
D-dimer, 6 Deep inltrating endometriosis (DIE)
bladder endometriosis, 257
diagnosis, 255
gastro-intestinal endometriosis, 260, 262
nerve-sparing surgery, 256
pathophysiology, 255
surgical approach, 256
treatment, 256
ureteral complications, 258–260
ureteral endometriosis, 257, 258
ureteral injury, 258–260 Deep organ space infections, 469 Delayed/missed ureteral injury, 443 Delayed wound healing, 468 Delorme’s procedure, 238 Delphi technique, 404 Denonvilliers fascia, 413 Direct oral anticoagulants (DOACs), 7 Discitis, 236, 237 Disruption of the mesentery, 358–359 Disseminated intravascular coagulation (DIC), 313,
325, 327 Donor site complications, 470 Donor site hernia, 469 Donor site morbidity, 464 Duodenum, 359 Dysuria, 120, 121
E
Early pregnancy loss, 313
Ectopic pregnancy
complications, 301 diagnosis, 301
medical and surgical management, 301 Electrolyte/biochemical imbalances, 435 Empty pelvis syndrome, 434 Endoluminal approaches, see Transanal local excision
(TAE) Endometritis, 299 Endopelvic fascia, 89 Endorectal advancement ap (ERAF), 213, 214 Endoscopic mucosal resection (EMR), 190 Endoscopic submucosal dissection (ESD), 190 Endosponge, 404 Enhanced recovery after surgery (ERAS)
history, 13 immunonutrition, 17 intraoperative considerations, 15 postoperative considerations, 15, 16 prehabilitation, 17 preoperative considerations, 14, 15 RC/PLND/UD, 13 thromboembolic events, 17
USC protocol, 14 Enteric stula, 433 Enterocutaneous stula, 160, 161 Entrapped ovary, 273 Estrogen-based contraception, 4 Extensive stulae, 470 Extensive subcutaneous edema, 434 External beam radiation therapy (EBRT), 417 External iliac vein, 353 Extra-levator abdominal perineal resection (ELAPE),
389
F
Fecal diversion, 344, 383, 403 Fecal incontinence (FI), 200
after radical vulvectomy, 344
anal insertion devices, 225
bowel function, 221
bulking agents, 226
complications, 395
denition, 221
diagnosis and evaluation, 222, 223
gynecologic malignancy, 222
OASIS, 221
prevention, 200
PTNS, 227
radiation therapy, 222
radiofrequency tissue remodeling, 226
recognition, 201
risk factors, 200
SNM, 227, 228
treatment, 201, 224, 225, 228
vaginal bowel control systems, 225, 226
VMR, 228 Female pelvic surgery
healing problems, 389
Index
475
locally progressive/recurrent disease, 389 pelvic exenteration (see Pelvic exenteration (PEx)) positive resection margins, 389
salvage surgeries, 389 Female pelvis, 286, 287 Female urethra, 280 Female urethrectomy
advancement meatoplasty, 106, 107
distal urethrectomy, 103, 106, 107
higher-stage urethral cancers, 104
meatal stenosis and distal urethral stricture, 105, 106
meatotomy, 106
noncancerous diseases, 105
pubovaginal slings, 112, 113
PUC, 103
radical urethrectomy, 104, 105
SUI, 107–112
surgical intervention, 105
vulvar and vaginal cancers, 105 Femoral nerve injuries, 451 Femoral triangle, 335 Fistulae, 469 Fistula-in-ano
anatomy, 210
ERAF, 213, 214
etiology, 209
stula plug/brin glue, 212
stulotomy, 211
history, 209
imaging, 211
LIFT, 212, 213
location, 210
minimally invasive techniques, 214, 215
seton placement, 211, 212
subcutaneous/submucosal stulas, 209
treatment, 211 Fistula laser tract closure (FiLaC), 214 Flap design, 465 Flap reconstruction, 463 Floating villi technique, 304 Fluid collections, 469 Fractures of pelvic ring and acetabulum, 454, 455 Frailty
aging, 23, 24
assessment, 24, 25
benets, 25, 26
denition, 23
geriatricians and geriatric care providers, 27, 28
health-related outcomes, 25
interventions, 26, 27 Fried Frailty Index, 24 Future pregnancy outcome, 305
Genital tract prolapse
bowel injury, 76 intraoperative injuries
management, 75 prevention, 73, 74 recognition, 74 sacrospinous ligament xation and sacral
colpopexy, 73 nerve injury, 76–78 post operative complications, 78 urinary tract injury, 75, 76
Genitourinary complications, 277–280 Geriatric comanagement, 27 Giant liposarcoma, 284 Gonadotropin releasing hormone (GnRH), 43 Gracilis myocutaneous ap, 342 Gracilis neosphincter/articial sphincter, 344 Groin dissection, 339 Groin pain, 85 GROINSS-V-1 prospective trial, 333 GROINSS-V-I study, 339 Gut microbiome, 35 Gynecologic cancers, 340 Gynecologic oncology, 441
H
Hardware failure, 455 Hematuria, 177 Hemipelvectomies, 451 Hemoperitoneum, 303 Hemorrhage, 320
after dilation and curettage/dilation and evacuation,
309 management, 63, 64 prevention, 62 recognition, 62, 63 risk factors, 61
Hernia, 436 Horseshoe abscess, 208 Human chorionic gonadotropin (hGC), 301 Hypogastric (internal iliac) arteries and veins, 283 Hysterectomy, 307
bladder injury, 64–66 bowel injury, 67, 68 hemorrhage
management, 63, 64 recognition, 62, 63
risk factors, 61 indications, 61 prevention, 62 ureteral injury, 66, 67 vaginal cuff dehiscence, 68, 69
G
Gastrointestinal (GI) complications, 15 Gastro-intestinal endometriosis, 260, 262 General emotional support in preoperative and
postoperative phases, 344
Generous meatotomy, 95
I
Ileal conduit urinary diversion
anastomotic leak, 161 conduit necrosis, 161 enterocutaneous stula, 160, 161